|
|
|
11.08.25 - 22:09
|
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results (Business Wire)
|
|
Marks major milestone with completion of enrollment in pivotal Phase 3 NEAT clinical trial evaluating lead asset, eDSP, for the treatment of A-T; topline results expected in first quarter of 2026
Closed financing priced at a premium bringing existing cash position to approximately $35 million; expected to provide runway through Phase 3 topline results and into at least second quarter of 2026
Entered into strategic relationship with Option Care Health to support commercial launch of eDSP in the U.S.SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an update on the company's development pipeline and reported financial results for the second quarter ended June 30, 2025.
Dirk Thye, M.D., Quince's Chief Executive Officer and Chief Medical Officer, said, “We achieved many critical milestones over the last quar...
|
|
|
|
|
|
25.06.25 - 22:09
|
Option Care Health to Announce Second Quarter 2025 Financial Results and Host Conference Call (GlobeNewswire EN)
|
|
BANNOCKBURN, Ill., June 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2025 on Wednesday, July 30, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day....
|
|
|
|
|
|
|
|
|
|
|
|
24.03.25 - 21:09
|
Option Care Health to Announce First Quarter 2025 Financial Results and Host Conference Call (GlobeNewswire EN)
|
|
BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day....
|
|
|